Phosphocreatine attenuates doxorubicin-induced nephrotoxicity through inhibition of apoptosis, and restore mitochondrial function via activation of Nrf2 and PGC-1α pathways.

MLA

Qaed, Eskandar, et al. “Phosphocreatine Attenuates Doxorubicin-Induced Nephrotoxicity through Inhibition of Apoptosis, and Restore Mitochondrial Function via Activation of Nrf2 and PGC-1α Pathways.” Chemico-Biological Interactions, vol. 400, Sept. 2024, p. 111147. EBSCOhost, https://doi.org/10.1016/j.cbi.2024.111147.

APA

Qaed, E., Almaamari, A., Almoiliqy, M., Alyafeai, E., Sultan, M., Aldahmash, W., Mahyoub, M. A., & Tang, Z. (2024). Phosphocreatine attenuates doxorubicin-induced nephrotoxicity through inhibition of apoptosis, and restore mitochondrial function via activation of Nrf2 and PGC-1α pathways. Chemico-Biological Interactions, 400, 111147. https://doi.org/10.1016/j.cbi.2024.111147

Chicago

Qaed, Eskandar, Ahmed Almaamari, Marwan Almoiliqy, Eman Alyafeai, Marwa Sultan, Waleed Aldahmash, Mueataz A Mahyoub, and Zeyao Tang. 2024. “Phosphocreatine Attenuates Doxorubicin-Induced Nephrotoxicity through Inhibition of Apoptosis, and Restore Mitochondrial Function via Activation of Nrf2 and PGC-1α Pathways.” Chemico-Biological Interactions 400 (September): 111147. doi:10.1016/j.cbi.2024.111147.